Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

April 1, 2025

Conditions
Nuclear Cataract
Interventions
OTHER

High Intraocular Pressure (IOP)

Prospective, single-surgeon, randomized, paired-eye study; patients undergoing sequential, uncomplicated bilateral phacoemulsification using Active Sentry handpiece® with Intraocular Pressure (IOP) ≤ 24 millimeters of mercury (mmHg) (low IOP) in one eye and with IOP ≥ 65 millimeters of mercury (mmHg) (high IOP) in the other eye.

OTHER

Low Intraocular Pressure (IOP)

Low Intraocular Pressure (IOP) Prospective, single-surgeon, randomized, paired-eye study; patients undergoing sequential, uncomplicated bilateral phacoemulsification using Active Sentry handpiece® with intraocular IOP ≤ 24 millimeters of mercury (mmHg) (low IOP) in one eye and with IOP ≥ 65 millimeters of mercury (mmHg) (high IOP) in the other eye

Trial Locations (1)

50266

Wolfe Eye Clinic, West Des Moines

All Listed Sponsors
lead

Matthew Rauen

OTHER

NCT06325397 - Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP) | Biotech Hunter | Biotech Hunter